» Articles » PMID: 12792220

Evidence of Active Cytomegalovirus Infection and Increased Production of IL-6 in Tissue Specimens Obtained from Patients with Inflammatory Bowel Diseases

Overview
Specialty Gastroenterology
Date 2003 Jun 7
PMID 12792220
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Recent reports have focused interest on human cytomegalovirus (HCMV) in inflammatory bowel diseases (IBD). Our aim in this study was to examine the frequency of HCMV-infected intestinal cells in tissue sections obtained from patients with IBD, and to investigate if HCMV-infected intestinal cells produce the proinflammatory cytokine IL-6. We studied intestinal tissue sections from 13 patients with ulcerative colitis, 10 with Crohn's disease, 10 cancer patients without intestinal inflammation, and 10 samples from HCMV-infected AIDS patients. HCMV-DNA was detected by in situ hybridization in sections obtained from 12/13 patients with ulcerative colitis, in 10 with Crohn's disease, in 10/10 samples from HCMV-infected AIDS patients, but not in any of the 10 samples that were obtained from uninflamed tissues. HCMV-specific antigens were detected in samples from all HCMV-infected AIDS patients, in 11/13 sections from patients with ulcerative colitis, in 10/10 samples from patients with Crohn's disease, but not in sections from uninflamed tissues. Cells were double positive for an HCMV early antigen and IL-6 in 10/13 sections from patients with ulcerative colitis, in all patients with Crohn's disease, and in 4/10 samples from AIDS patients. In conclusion, these results suggest that active HCMV infection in the intestine is very frequent in patients with IBD, and may contribute to the inflammatory process through an increased production of IL-6.

Citing Articles

A new autochthonous case of amebiasis in Italy in a patient without risk factors: an alert for clinicians and laboratorians.

Corich L, Bramuzzo I, Perandin F, Treggiari D, Scarso S, Rigo S Infez Med. 2025; 33(1):125-129.

PMID: 40071264 PMC: 11892448. DOI: 10.53854/liim-3301-12.


Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment.

Maresca R, Varca S, Di Vincenzo F, Ainora M, Mignini I, Papa A J Clin Med. 2024; 13(1).

PMID: 38202138 PMC: 10779749. DOI: 10.3390/jcm13010130.


DNA damage response(DDR): a link between cellular senescence and human cytomegalovirus.

Wu X, Zhou X, Wang S, Mao G Virol J. 2023; 20(1):250.

PMID: 37915066 PMC: 10621139. DOI: 10.1186/s12985-023-02203-y.


Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer.

Pantalone M, Almazan N, Lattanzio R, Taher C, De Fabritiis S, Valentinuzzi S Int J Oncol. 2023; 63(5).

PMID: 37654195 PMC: 10546380. DOI: 10.3892/ijo.2023.5564.


Human Cytomegalovirus Seropositivity and Viral DNA in Breast Tumors Are Associated with Poor Patient Prognosis.

Yang Z, Tang X, Hasing M, Pang X, Ghosh S, McMullen T Cancers (Basel). 2022; 14(5).

PMID: 35267456 PMC: 8909033. DOI: 10.3390/cancers14051148.